1
|
Griebsch C, Kirkwood N, Ward MP, Norris JM. Serological evidence of exposure of healthy dogs to Leptospira in Sydney, New South Wales, Australia. Aust Vet J 2024; 102:215-221. [PMID: 38220214 DOI: 10.1111/avj.13315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 12/17/2023] [Accepted: 12/20/2023] [Indexed: 01/16/2024]
Abstract
In 2017, highly fatal canine leptospirosis emerged in Sydney, Australia. Based on results of microscopic agglutination testing (MAT), serovar Copenhageni appeared to be the most common causative serovar. Prior to this, no clinical cases had been reported since 1976. In a serosurvey of healthy dogs in Australian shelters in 2004, 2.4% of 431 New South Wales dogs had serological evidence of exposure to Copenhageni, the most prevalent serovar. The aim of this study was to estimate the current prevalence of Leptospira exposure and associated serovars in healthy Sydney dogs, previously unvaccinated against Leptospira. Serum samples from 411 healthy dogs in leptospirosis hotspots and neighbouring suburbs were collected before vaccination. MAT for 23 serovars was performed at the WHO Leptospirosis Reference Laboratory in Queensland, Australia. The overall seroprevalence was 4.1% (17/411) with low titres (1/50-1/200) detected. Eleven dogs were from known leptospirosis hotspots. Eight dogs were known to hunt rodents. One dog had been in contact with a leptospirosis positive dog 1 year prior. Serovar Topaz was the most prevalent serovar (n = 5) followed by serovars Australis (n = 4), Copenhageni (n = 4), Djasiman (n = 2), Cynopteri (n = 1), Javanica (n = 1), Medanensis (n = 1), and Pomona (n = 1). In conclusion, serological evidence of exposure of dogs in Sydney to Leptospira is low, but apparently has increased since 2004. Positive titres to serovars not previously reported to cause disease in dogs could be due to low virulence of those serovars or cross-reactivity with other serovars.
Collapse
Affiliation(s)
- C Griebsch
- Sydney School of Veterinary Science, University of Sydney, Camperdown, New South Wales, 2006, Australia
| | - N Kirkwood
- Sydney School of Veterinary Science, University of Sydney, Camperdown, New South Wales, 2006, Australia
| | - M P Ward
- Sydney School of Veterinary Science, University of Sydney, Camperdown, New South Wales, 2006, Australia
| | - J M Norris
- Sydney School of Veterinary Science, University of Sydney, Camperdown, New South Wales, 2006, Australia
| |
Collapse
|
2
|
Sykes JE, Francey T, Schuller S, Stoddard RA, Cowgill LD, Moore GE. Updated ACVIM consensus statement on leptospirosis in dogs. J Vet Intern Med 2023; 37:1966-1982. [PMID: 37861061 PMCID: PMC10658540 DOI: 10.1111/jvim.16903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2023] [Accepted: 09/29/2023] [Indexed: 10/21/2023] Open
Abstract
Since publication of the last consensus statement on leptospirosis in dogs, there has been revision of leptospiral taxonomy and advancements in typing methods, widespread use of new diagnostic tests and vaccines, and improved understanding of the epidemiology and pathophysiology of the disease. Leptospirosis continues to be prevalent in dogs, including in small breed dogs from urban areas, puppies as young as 11 weeks of age, geriatric dogs, dogs in rural areas, and dogs that have been inadequately vaccinated for leptospirosis (including dogs vaccinated with 2-serovar Leptospira vaccines in some regions). In 2021, the American College of Veterinary Internal Medicine (ACVIM) Board of Regents voted to approve the topic for a revised Consensus Statement. After identification of core panelists, a multidisciplinary group of 6 experts from the fields of veterinary medicine, human medicine, and public health was assembled to vote on the recommendations using the Delphi method. A draft was presented at the 2023 ACVIM Forum, and a written draft posted on the ACVIM website for comment by the membership before submission to the editors of the Journal of Veterinary Internal Medicine. This revised document provides guidance for veterinary practitioners on disease in dogs as well as cats. The level of agreement among the 12 voting members (including core panelists) is provided in association with each recommendation. A denominator lower than 12 reflects abstention of ≥1 panelists either because they considered the recommendation to be outside their scope of expertise or because there was a perceived conflict of interest.
Collapse
Affiliation(s)
- Jane E. Sykes
- Department of Medicine and EpidemiologyUniversity of California, DavisDavisCalifornia95616USA
| | - Thierry Francey
- Department of Clinical Veterinary ScienceVetsuisse Faculty, University of BernBernSwitzerland
| | - Simone Schuller
- Department of Clinical Veterinary ScienceVetsuisse Faculty, University of BernBernSwitzerland
| | - Robyn A. Stoddard
- Bacterial Special Pathogens BranchCenters for Disease Control and PreventionAtlantaGeorgia30333USA
| | - Larry D Cowgill
- Department of Medicine and EpidemiologyUniversity of California, DavisDavisCalifornia95616USA
| | - George E. Moore
- Department of Veterinary AdministrationPurdue UniversityWest Lafayette, Indiana 47907USA
| |
Collapse
|
3
|
Smith AM, Stull JW, Moore GE. Potential Drivers for the Re-Emergence of Canine Leptospirosis in the United States and Canada. Trop Med Infect Dis 2022; 7:377. [PMID: 36422928 PMCID: PMC9694660 DOI: 10.3390/tropicalmed7110377] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Revised: 11/10/2022] [Accepted: 11/11/2022] [Indexed: 09/03/2023] Open
Abstract
Canine leptospirosis is an important zoonotic disease in many countries. This review examines potential drivers for increased diagnoses of canine leptospirosis in the United States and Canada, using the epidemiologic triad of agent-environment-host as a template. Leptospira spp. are classified into more than 250 serovars, but in many laboratories only 6 are routinely tested for in serologic agglutination tests of canine sera. Leptospiral infections in dogs may potentially go undetected with unemployed or currently employed diagnostic methods. Disease transmission from infected reservoir hosts usually occurs via urine-contaminated environmental sources such as water. Direct contact between infected and susceptible individuals, environmental factors such as climate changes in temperature and/or rainfall, and increasing number and urbanization of reservoir hosts may greatly increase dog exposure risks. A dog's lifestyle may influence exposure risk to leptospirosis, but vaccination based on proper identification of circulating serogroups dramatically reduces post-exposure infections. Regrettably, resistance to vaccination by veterinarians and dog owners leaves a large number of dogs at risk for this zoonotic disease.
Collapse
Affiliation(s)
- Amanda M. Smith
- College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA
| | - Jason W. Stull
- College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA
- Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE CIA 4P3, Canada
| | - George E. Moore
- College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA
| |
Collapse
|
4
|
Abstract
These guidelines are an update and extension of previous AAHA peer-reviewed canine vaccination guidelines published in 2017. Vaccination is a cornerstone of canine preventive healthcare and one of the most cost-effective ways of maintaining a dog's health, longevity, and quality of life. Canine vaccination also serves a public health function by forming a barrier against several zoonotic diseases affecting dogs and humans. Canine vaccines are broadly categorized as containing core and noncore immunizing antigens, with administration recommendations based on assessment of individual patient risk factors. The guidelines include a comprehensive table listing canine core and noncore vaccines and a recommended vaccination and revaccination schedule for each vaccine. The guidelines explain the relevance of different vaccine formulations, including those containing modified-live virus, inactivated, and recombinant immunizing agents. Factors that potentially affect vaccine efficacy are addressed, including the patient's prevaccination immune status and vaccine duration of immunity. Because animal shelters are one of the most challenging environments for prevention and control of infectious diseases, the guidelines also provide recommendations for vaccination of dogs presented at or housed in animal shelters, including the appropriate response to an infectious disease outbreak in the shelter setting. The guidelines explain how practitioners can interpret a patient's serological status, including maternally derived antibody titers, as indicators of immune status and suitability for vaccination. Other topics covered include factors associated with postvaccination adverse events, vaccine storage and handling to preserve product efficacy, interpreting product labeling to ensure proper vaccine use, and using client education and healthcare team training to raise awareness of the importance of vaccinations.
Collapse
Affiliation(s)
- John Ellis
- University of Saskatchewan, Department of Veterinary Microbiology, Saskatoon, Saskatchewan (J.E.)
| | | | - Chumkee Aziz
- Association of Shelter Veterinarians, Houston, Texas (C.A.)
| | - Catherine M Brown
- Massachusetts Department of Public Health, Boston, Massachusetts (C.M.B.)
| | - Leah A Cohn
- University of Missouri, Columbia, Missouri (L.A.C.)
| | | | - George E Moore
- Purdue University, College of Veterinary Medicine, West Lafayette, Indiana (G.E.M.)
| | - Neha Taneja
- A Paw Partnership, Veterinary Well-being Advocate, Centreville, Virginia (N.T.)
| |
Collapse
|
5
|
Reagan KL, Deng S, Sheng J, Sebastian J, Wang Z, Huebner SN, Wenke LA, Michalak SR, Strohmer T, Sykes JE. Use of machine-learning algorithms to aid in the early detection of leptospirosis in dogs. J Vet Diagn Invest 2022; 34:612-621. [PMID: 35603565 PMCID: PMC9266510 DOI: 10.1177/10406387221096781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Leptospirosis is a life-threatening, zoonotic disease with various clinical presentations, including renal injury, hepatic injury, pancreatitis, and pulmonary hemorrhage. With prompt recognition of the disease and treatment, 90% of infected dogs have a positive outcome. Therefore, rapid, early diagnosis of leptospirosis is crucial. Testing for Leptospira-specific serum antibodies using the microscopic agglutination test (MAT) lacks sensitivity early in the disease process, and diagnosis can take >2 wk because of the need to demonstrate a rise in titer. We applied machine-learning algorithms to clinical variables from the first day of hospitalization to create machine-learning prediction models (MLMs). The models incorporated patient signalment, clinicopathologic data (CBC, serum chemistry profile, and urinalysis = blood work [BW] model), with or without a MAT titer obtained at patient intake (=BW + MAT model). The models were trained with data from 91 dogs with confirmed leptospirosis and 322 dogs without leptospirosis. Once trained, the models were tested with a cohort of dogs not included in the model training (9 leptospirosis-positive and 44 leptospirosis-negative dogs), and performance was assessed. Both models predicted leptospirosis in the test set with 100% sensitivity (95% CI: 70.1–100%). Specificity was 90.9% (95% CI: 78.8–96.4%) and 93.2% (95% CI: 81.8–97.7%) for the BW and BW + MAT models, respectively. Our MLMs outperformed traditional acute serologic screening and can provide accurate early screening for the probable diagnosis of leptospirosis in dogs.
Collapse
Affiliation(s)
- Krystle L. Reagan
- Department of Medicine and Epidemiology, University of California–Davis, Davis, CA, USA
| | - Shaofeng Deng
- School of Veterinary Medicine, and Department of Mathematics, University of California–Davis, Davis, CA, USA
| | - Junda Sheng
- School of Veterinary Medicine, and Department of Mathematics, University of California–Davis, Davis, CA, USA
| | - Jamie Sebastian
- William R. Pritchard Veterinary Medical Teaching Hospital, University of California–Davis, Davis, CA, USA
| | - Zhe Wang
- William R. Pritchard Veterinary Medical Teaching Hospital, University of California–Davis, Davis, CA, USA
| | - Sara N. Huebner
- William R. Pritchard Veterinary Medical Teaching Hospital, University of California–Davis, Davis, CA, USA
| | - Louise A. Wenke
- William R. Pritchard Veterinary Medical Teaching Hospital, University of California–Davis, Davis, CA, USA
| | - Sarah R. Michalak
- William R. Pritchard Veterinary Medical Teaching Hospital, University of California–Davis, Davis, CA, USA
| | - Thomas Strohmer
- School of Veterinary Medicine, and Department of Mathematics, University of California–Davis, Davis, CA, USA
| | - Jane E. Sykes
- Department of Medicine and Epidemiology, University of California–Davis, Davis, CA, USA
| |
Collapse
|
6
|
Sykes JE, Reagan KL, Nally JE, Galloway RL, Haake DA. Role of Diagnostics in Epidemiology, Management, Surveillance, and Control of Leptospirosis. Pathogens 2022; 11:395. [PMID: 35456070 PMCID: PMC9032781 DOI: 10.3390/pathogens11040395] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Revised: 03/22/2022] [Accepted: 03/22/2022] [Indexed: 12/12/2022] Open
Abstract
A One Health approach to the epidemiology, management, surveillance, and control of leptospirosis relies on accessible and accurate diagnostics that can be applied to humans and companion animals and livestock. Diagnosis should be multifaceted and take into account exposure risk, clinical presentation, and multiple direct and/or indirect diagnostic approaches. Methods of direct detection of Leptospira spp. include culture, histopathology and immunostaining of tissues or clinical specimens, and nucleic acid amplification tests (NAATs). Indirect serologic methods to detect leptospiral antibodies include the microscopic agglutination test (MAT), the enzyme-linked immunosorbent assay (ELISA), and lateral flow methods. Rapid diagnostics that can be applied at the point-of-care; NAAT and lateral flow serologic tests are essential for management of acute infection and control of outbreaks. Culture is essential to an understanding of regional knowledge of circulating strains, and we discuss recent improvements in methods for cultivation, genomic sequencing, and serotyping. We review the limitations of NAATs, MAT, and other diagnostic approaches in the context of our expanding understanding of the diversity of pathogenic Leptospira spp. Novel approaches are needed, such as loop mediated isothermal amplification (LAMP) and clustered regularly interspaced short palindromic repeats (CRISPR)-based approaches to leptospiral nucleic acid detection.
Collapse
|